# Belatacept in Heart Transplantation

> **NCT06478017** · PHASE2 · RECRUITING · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 66 (estimated)

## Conditions studied

- Heart Transplant

## Interventions

- **DRUG:** Belatacept
- **DRUG:** Tacrolimus
- **DRUG:** Mycophenolate Mofetil/Sodium
- **DRUG:** Prednisone

## Key facts

- **NCT ID:** NCT06478017
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-01-29
- **Primary completion:** 2028-01-31
- **Final completion:** 2028-01-31
- **Target enrollment:** 66 (ESTIMATED)
- **Last updated:** 2026-04-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06478017

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06478017, "Belatacept in Heart Transplantation". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06478017. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*